Annals of Colorectal Research

Published by: Kowsar

Clinical and Pathological Characteristics of Mucinous Colorectal Adenocarcinoma: A Comparative Study

Sare Hosseini 1 , Shadi Zohourinia 2 , Mohammad Zare-Bandamiri 3 , Maral Mokhtari 4 , Soudabeh Pourhashemi 5 , Massood Hosseinzadeh 4 and Mohammad Mohammadianpanah 4 , *
Authors Information
1 Cancer Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
2 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, IR Iran
3 Department of Radiation Oncology, Shiraz University of Medical Sciences, Shiraz, IR Iran
4 Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
5 Department of Biostatistics, Medical School, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Annals of Colorectal Research: March 01, 2016, 4 (1); e34404
  • Published Online: March 1, 2016
  • Article Type: Research Article
  • Received: November 5, 2015
  • Accepted: November 30, 2015
  • DOI: 10.17795/acr-34404

To Cite: Hosseini S, Zohourinia S, Zare-Bandamiri M, Mokhtari M, Pourhashemi S, et al. Clinical and Pathological Characteristics of Mucinous Colorectal Adenocarcinoma: A Comparative Study, Ann Colorectal Res. 2016 ; 4(1):e34404. doi: 10.17795/acr-34404.

Abstract
Copyright © 2016, Colorectal Research Center and Health Policy Research Center of Shiraz University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Edwards BK, Noone A, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, et al. Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014; 120(9): 1290-314[PubMed]
  • 2. Hoseini S, Moaddabshoar L, Hemati S, Mohammadianpanah M. An Overview of Clinical and Pathological Characteristics and Survival Rate of Colorectal Cancer in Iran. Ann colorectal res. 2014; 2(1)[DOI]
  • 3. Debunne H, Ceelen W. Mucinous differentiation in colorectal cancer: molecular, histological and clinical aspects. Acta Chir Belg. 2013; 113(6): 385-90[PubMed]
  • 4. Perez-Villamil B, Romera-Lopez A, Hernandez-Prieto S, Lopez-Campos G, Calles A, Lopez-Asenjo JA, et al. Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior. BMC Cancer. 2012; 12: 260[DOI][PubMed]
  • 5. Verhulst J, Ferdinande L, Demetter P, Ceelen W. Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis. J Clin Pathol. 2012; 65(5): 381-8[DOI][PubMed]
  • 6. Hyngstrom JR, Hu CY, Xing Y, You YN, Feig BW, Skibber JM, et al. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol. 2012; 19(9): 2814-21[DOI][PubMed]
  • 7. Jivapaisarnpong P, Boonthongtho K. Clinicopathological characteristics of mucinous and non-mucinous adenocarcinoma in the colon and rectum in Rajavithi Hospital, Thailand. J Med Assoc Thailand. 2011; 94-5
  • 8. Song W, Wu SJ, He YL, Cai SR, Zhang CH, Zhang XH, et al. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China. Chin Med J (Engl). 2009; 122(13): 1486-91[PubMed]
  • 9. Mekenkamp LJ, Heesterbeek KJ, Koopman M, Tol J, Teerenstra S, Venderbosch S, et al. Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer. Eur J Cancer. 2012; 48(4): 501-9[DOI][PubMed]
  • 10. Safaee A, Moghimi-Dehkordi B, Fatemi SR, Ghiasi S, Nemati-Malek F, Zali MR. Characteristics of colorectal mucinous adenocarcinoma in Iran. Asian Pac J Cancer Prev. 2010; 11(5): 1373-5[PubMed]
  • 11. Frederick LG, David LP, Irvin DF, April GF, Charles MB, Daniel GH, et al. American Joint Committee on Cancer, AJCC Cancer Staging Manual. 2010; : 143
  • 12. Jimi S, Hotokezaka M, Ikeda T, Uchiyama S, Hidaka H, Maehara N, et al. Clinicopathological features, postoperative survival and prognostic variables for cancer-related survival in patients with mucinous colorectal carcinoma. Surg Today. 2015; 45(3): 329-34[DOI][PubMed]
  • 13. Park JS, Huh JW, Park YA, Cho YB, Yun SH, Kim HC, et al. Prognostic comparison between mucinous and nonmucinous adenocarcinoma in colorectal cancer. Medicine (Baltimore). 2015; 94(15)[DOI][PubMed]
  • 14. Maeda Y, Sadahiro S, Suzuki T, Haruki Y, Nakamura N. Significance of the mucinous component in the histopathological classification of colon cancer. Surg Today. 2015; [DOI][PubMed]
  • 15. Numata M, Shiozawa M, Watanabe T, Tamagawa H, Yamamoto N, Morinaga S, et al. The clinicopathological features of colorectal mucinous adenocarcinoma and a therapeutic strategy for the disease. World J Surg Oncol. 2012; 10: 109[DOI][PubMed]
  • 16. Du W, Mah JT, Lee J, Sankila R, Sankaranarayanan R, Chia KS. Incidence and survival of mucinous adenocarcinoma of the colorectum: a population-based study from an Asian country. Dis Colon Rectum. 2004; 47(1): 78-85[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments